News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,329 Results
Type
Article (44163)
Company Profile (278)
Press Release (660888)
Section
Business (206185)
Career Advice (2138)
Deals (35672)
Drug Delivery (97)
Drug Development (81511)
Employer Resources (173)
FDA (16294)
Job Trends (15063)
News (348298)
Policy (32844)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (6)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2668)
Accelerated approval (2)
Adcomms (21)
Allergies (77)
Alliances (50054)
ALS (74)
Alzheimer's disease (1330)
Antibody-drug conjugate (ADC) (100)
Approvals (16279)
Artificial intelligence (216)
Autoimmune disease (11)
Automation (14)
Bankruptcy (360)
Best Places to Work (11771)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (199)
Bladder cancer (51)
Brain cancer (23)
Breast cancer (231)
Cancer (1802)
Cardiovascular disease (136)
Career advice (1781)
Career pathing (29)
CAR-T (135)
Cell therapy (389)
Cervical cancer (13)
Clinical research (65705)
Collaboration (713)
Compensation (403)
Complete response letters (18)
COVID-19 (2598)
CRISPR (34)
C-suite (181)
Cystic fibrosis (99)
Data (1716)
Decentralized trials (2)
Denatured (14)
Depression (38)
Diabetes (223)
Diagnostics (6350)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (105)
Drug pricing (98)
Drug shortages (26)
Duchenne muscular dystrophy (63)
Earnings (85996)
Editorial (28)
Employer branding (22)
Employer resources (148)
Events (112406)
Executive appointments (592)
FDA (17261)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (638)
Gene editing (91)
Generative AI (20)
Gene therapy (261)
GLP-1 (669)
Government (4433)
Grass and pollen (4)
Guidances (45)
Healthcare (19027)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (92)
Indications (23)
Infectious disease (2718)
Inflammatory bowel disease (124)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (70)
Interviews (341)
IPO (16539)
IRA (41)
Job creations (3735)
Job search strategy (1518)
Kidney cancer (9)
Labor market (26)
Layoffs (450)
Leadership (14)
Legal (7986)
Liver cancer (69)
Lung cancer (261)
Lymphoma (120)
Machine learning (2)
Management (58)
Manufacturing (246)
MASH (58)
Medical device (13456)
Medtech (13461)
Mergers & acquisitions (19534)
Metabolic disorders (583)
Multiple sclerosis (58)
NASH (16)
Neurodegenerative disease (68)
Neuropsychiatric disorders (24)
Neuroscience (1759)
NextGen: Class of 2025 (6659)
Non-profit (4557)
Northern California (2224)
Now hiring (35)
Obesity (320)
Opinion (210)
Ovarian cancer (61)
Pain (68)
Pancreatic cancer (68)
Parkinson's disease (117)
Partnered (17)
Patents (181)
Patient recruitment (80)
Peanut (45)
People (57687)
Pharmaceutical (66)
Pharmacy benefit managers (19)
Phase I (20518)
Phase II (28940)
Phase III (21515)
Pipeline (805)
Podcasts (42)
Policy (102)
Postmarket research (2569)
Preclinical (8722)
Press Release (67)
Prostate cancer (84)
Psychedelics (32)
Radiopharmaceuticals (245)
Rare diseases (343)
Real estate (6018)
Recruiting (66)
Regulatory (22208)
Reports (43)
Research institute (2387)
Resumes & cover letters (360)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (61)
Series A (116)
Series B (69)
Service/supplier (12)
Sickle cell disease (53)
Southern California (1894)
Special edition (14)
Sponsored (28)
Startups (3654)
State (2)
Stomach cancer (11)
Supply chain (56)
The Weekly (27)
United States (19524)
Vaccines (628)
Venture capitalists (34)
Webinars (12)
Weight loss (219)
Women's health (30)
Worklife (14)
Date
Today (185)
Last 7 days (818)
Last 30 days (2946)
Last 365 days (34759)
2025 (5645)
2024 (35573)
2023 (40413)
2022 (51542)
2021 (56125)
2020 (54562)
2019 (47273)
2018 (35597)
2017 (32629)
2016 (32086)
2015 (38681)
2014 (32491)
2013 (27571)
2012 (29126)
2011 (29861)
2010 (27791)
Location
Africa (752)
Alabama (49)
Alaska (7)
Arizona (214)
Arkansas (13)
Asia (38463)
Australia (6336)
California (5059)
Canada (1768)
China (416)
Colorado (231)
Connecticut (246)
Delaware (110)
Europe (83181)
Florida (750)
Georgia (175)
Idaho (57)
Illinois (468)
India (20)
Indiana (274)
Iowa (7)
Japan (128)
Kansas (101)
Kentucky (24)
Louisiana (7)
Maine (59)
Maryland (775)
Massachusetts (3873)
Michigan (203)
Minnesota (350)
Mississippi (2)
Missouri (71)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (63)
New Jersey (1419)
New Mexico (27)
New York (1440)
North Carolina (871)
North Dakota (8)
Northern California (2224)
Ohio (179)
Oklahoma (14)
Oregon (33)
Pennsylvania (1148)
Puerto Rico (7)
Rhode Island (23)
South America (1136)
South Carolina (13)
South Dakota (1)
Southern California (1894)
Tennessee (83)
Texas (741)
Utah (157)
Virginia (118)
Washington D.C. (54)
Washington State (483)
West Virginia (3)
Wisconsin (45)
705,329 Results for "bal seal engineering inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting
February 13, 2025
·
4 min read
Press Releases
CORRECTING and REPLACING Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting
February 24, 2025
·
4 min read
Press Releases
Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease
January 23, 2025
·
9 min read
Press Releases
MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
January 23, 2025
·
4 min read
Press Releases
Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers
December 18, 2024
·
5 min read
Drug Development
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
Agenus Inc. today announced it will conduct a Type B End-of-Phase 2 (EOP2) meeting in July with the U.S. Food and Drug Administration (FDA) to discuss the botensilimab plus balstilimab (BOT/BAL).
May 16, 2024
·
4 min read
Drug Development
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
Agenus Inc. today announced updated results from its Phase 1 clinical trial of BOT/BAL combination therapy in patients with metastatic CRC that is not microsatellite instability-high (MSS) or deficient mismatch repair (dMMR).
April 12, 2024
·
3 min read
Press Releases
Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development
November 13, 2024
·
7 min read
BioForest
Seal Rock Therapeutics to Present Preclinical Efficacy Findings for SRT-015 in Cholestatic Liver Diseases at the European Association for Study of the Liver (EASL) Congress 2024
Seal Rock Therapeutics, Inc. today announced that it will present preclinical data on SRT-015 for severe cholestatic disease during a poster presentation at the European Association for Study of the Liver (EASL) Congress 2024 being held June 5-8, 2024, in Milan, Italy.
May 29, 2024
·
2 min read
Press Releases
Signati™ Medical Successfully Completes IDE Trial for Separo™ Vessel Sealing System and Initiates FDA Market Clearance Process
December 23, 2024
·
2 min read
1 of 70,533
Next
